ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,752Medicare Part D Prescriptions Filled, Including Refills

Rank: 180 out of 2588

$937K Total Retail Price of All Prescriptions

Rank: 107 out of 2588

410 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 410 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

14% of this provider’s 410 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 12,642 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 592 548 1 2
OMEPRAZOLE 576 520 2 6
SIMVASTATIN 508 480 3 1
FUROSEMIDE 405 390 4 5
AMLODIPINE BESYLATE 392 371 5 4
LISINOPRIL 346 297 6 3
DONEPEZIL HCL 336 335 7 22
WARFARIN SODIUM 303 296 8 10
NAMENDA 301 301 9 32
ATORVASTATIN CALCIUM 276 235 10 11
ALENDRONATE SODIUM 276 275 10 21
METOPROLOL TARTRATE 261 242 12 9
HYDROCODONE-ACETAMINOPHEN 258 246 S3 13 7
FENOFIBRATE 228 206 14 64
GABAPENTIN 220 200 15 18
METFORMIN HCL 210 171 16 8
LIDODERM 162 162 17 86
SERTRALINE HCL 158 150 18 26
CITALOPRAM HBR 148 140 19 27
KLOR-CON M10 138 138 20 139
POTASSIUM CHLORIDE 137 130 21 15
NOVOLOG 131 115 22 103
KLOR-CON M20 128 128 23 52
METOPROLOL SUCCINATE 128 100 23 12
SPIRIVA 117 109 25 56
GLIPIZIDE 117 105 25 44
LEVOFLOXACIN 112 104 27 77
ZOLPIDEM TARTRATE 111 71 28 24
LOSARTAN POTASSIUM 109 109 29 17
HYDROCHLOROTHIAZIDE 107 103 30 13
IPRATROPIUM-ALBUTEROL 105 105 31 104
LANTUS 105 77 31 47
ADVAIR DISKUS 105 98 31 48
DIOVAN 104 82 34 29
JANUVIA 104 97 34 60
FLUTICASONE PROPIONATE 100 92 36 40
RISPERIDONE 96 96 37 57
AZITHROMYCIN 93 85 38 45
CLOPIDOGREL 90 89 39 30
NIASPAN 89 51 40 115
FENTANYL 86 86 S2 41 78
TAMSULOSIN HCL 85 83 42 23
LOVASTATIN 83 75 43 34
CRESTOR 83 80 43 25
PRAVASTATIN SODIUM 82 68 45 16
DIGOXIN 81 81 46 38
CARBIDOPA-LEVODOPA 80 80 47 83
BUMETANIDE 78 76 48 117
TRAMADOL HCL 76 69 49 19
ATENOLOL 76 68 49 14
PANTOPRAZOLE SODIUM 75 74 51 28
ESCITALOPRAM OXALATE 74 74 52 68
OXYBUTYNIN CHLORIDE ER 71 60 53 85
SINGULAIR 71 67 53 94
ALLOPURINOL 70 63 55 33
ENALAPRIL MALEATE 68 52 56 31
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 60 57 127
PLAVIX 63 63 58 43
CIPROFLOXACIN HCL 62 59 59 82
IPRATROPIUM BROMIDE 61 61 60 159
COMBIVENT 59 53 61 145
PREDNISONE 59 58 61 42
CYMBALTA 57 51 63 70
PROAIR HFA 55 21 64 50
ALBUTEROL SULFATE 54 54 65 116
CARVEDILOL 54 54 65 20
MIRTAZAPINE 51 51 67 63
PAROXETINE HCL 50 34 68 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.